Akeso completes patient enrolment for cadonilimab Phase III registrational clinical trial
Jazz Pharmaceuticals to acquire Chimerix in USD935m deal to expand oncology portfolio
Dermata Therapeutics completes treatment in XYNGARI Phase 3 acne trial
Bloom Science's BL-001 shows positive results in Phase 1 trial
Heyou Hospital, China orders treatment planning system from RaySearch
ONWARD Medical secures funding to advance Parkinson's disease research
Latigo Biotherapeutics' LTG-001 receives US FDA Fast Track designation
Raziel and Fosun Pharma commence phase 3 RZL-012 study in China
CStone Pharmaceuticals reports first patient dosed in CS2009 Phase I trial
Celltrion's STOBOCLO and OSENVELT biosimilars receive US FDA approval
Faron Pharmaceuticals' bexmarilimab receives FDA Orphan Drug Designation for MDS
Protagonist and Takeda report positive Phase 3 results for rusfertide in polycythemia vera
GSK demonstrates significant improvement in CRSwNP treatment with depemokimab at 2025 AAAAI
Australia declines approval for BioArctic and Eisai's Alzheimer's drug lecanemab